D B483
Alternative Names: 111In D6 B483; D-B483; HD6-DOTA-111InLatest Information Update: 17 May 2021
At a glance
- Originator Ashvattha Therapeutics
- Class Imaging agents; Radiopharmaceutical diagnostics
- Mechanism of Action Radionuclide imaging enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Glioblastoma; Solid tumours